Genomic characterization of spleens in patients with myelofibrosis

• Eran Zimran,
• Joseph Tripodi,
• Raajit Rampal,
• Franck Rappoport,
• Sharon Zirkiev,
• Ronald Hoffman,
• Vesna Najfeld

Affiliations

Eran Zimran

Myeloproliferative Neoplasms Research Program, Department of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Rockefeller University, New York, NY, USA

Joseph Tripodi

Myeloproliferative Neoplasms Research Program, Department of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Rockefeller University, New York, NY, USA;Tumor Cytogenomics Laboratory, Department of Pathology, Icahn School of Medicine at Mount Sinai, Rockefeller University, New York, NY, USA

Raajit Rampal

Human Oncology and Pathogenesis Program, Leukemia Service, Memorial Sloan-Kettering Cancer Center, Rockefeller University, New York, NY, USA

Franck Rappoport

Human Oncology and Pathogenesis Program, Leukemia Service, Memorial Sloan-Kettering Cancer Center, Rockefeller University, New York, NY, USA;Center for Clinical and Translational Science, Rockefeller University, New York, NY, USA

Sharon Zirkiev

Tumor Cytogenomics Laboratory, Department of Pathology, Icahn School of Medicine at Mount Sinai, Rockefeller University, New York, NY, USA

Ronald Hoffman

Myeloproliferative Neoplasms Research Program, Department of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Rockefeller University, New York, NY, USA

Vesna Najfeld

Myeloproliferative Neoplasms Research Program, Department of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Rockefeller University, New York, NY, USA;Tumor Cytogenomics Laboratory, Department of Pathology, Icahn School of Medicine at Mount Sinai, Rockefeller University, New York, NY, USA